Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data
Abstract Background Lafora disease (LD) is a fatal form of progressive myoclonic epilepsy caused by biallelic pathogenic variants in EPM2A or NHLRC1. With a few exceptions, the influence of genetic factors on disease progression has yet to be confirmed. We present a systematic review and meta-analys...
Main Authors: | Federica Pondrelli, Raffaella Minardi, Lorenzo Muccioli, Corrado Zenesini, Luca Vignatelli, Laura Licchetta, Barbara Mostacci, Paolo Tinuper, Craig W. Vander Kooi, Matthew S. Gentry, Francesca Bisulli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Orphanet Journal of Rare Diseases |
Online Access: | https://doi.org/10.1186/s13023-023-02880-6 |
Similar Items
-
Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis
by: Federica Pondrelli, et al.
Published: (2021-08-01) -
Treatment with metformin in twelve patients with Lafora disease
by: Francesca Bisulli, et al.
Published: (2019-06-01) -
Epilepsy With Auditory Features: From Etiology to Treatment
by: Alessandro Furia, et al.
Published: (2022-01-01) -
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease
by: Lorenzo Muccioli, et al.
Published: (2022-01-01) -
TELEmedicine for EPIlepsy Care (TELE-EPIC): protocol of a randomised, open controlled non-inferiority clinical trial
by: Emanuel Raschi, et al.
Published: (2021-12-01)